Search

The Adoption Communication Pathway(ACP) model was used to test the potential mediating effect of curiosity on adoption information seeking in a sample of 143 emerging adult adoptees (mean age = 25.0 years) who were adopted as infants within the United States by parents of the same race. Adoptees were interviewed about their intentions and actions taken to gather new information about their birth mothers and fathers. As expected, level of curiosity was positively associated with information seeking behavior. Moreover, level of curiosity was influenced by adoptees' perceptions of barriers and facilitators toward information-dseeking. In fact, curiosity partially mediated the impact of internal and external barriers on information seeking about birth mothers. Curiosity fully mediated the impact of external barriers and partially mediated external facilitators on birth father information seeking. This study provides important support for the ACP, which describes context, motivation, and behavior relating to seeking new adoption-related information.

Background: Few treatment options for alcohol use disorders (AUDs) exist and more are critically needed. Here, we assessed whether trace amine associated receptor 1 (TAAR1), a modulator of brain monoamine systems, is involved in the behavioral and reinforcement-related effects of ethanol and whether it could potentially serve as a therapeutic target., Methods: Wild-type (WT) and TAAR1 knockout (KO) mice (75% C57J/BL6 and 25% 129S1/Sv background) were compared in tests of ethanol consumption (two-bottle choice [TBC]), motor impairment (loss of righting reflex, [LORR], locomotor activity) and ethanol clearance (blood ethanol level [BEL])., Results: As compared with WT mice, KO mice displayed (1) significantly greater preference for and consumption of ethanol in a TBC paradigm (3%-11% vol/vol escalating over 10 weeks), with no significant difference observed in TBC with sucrose (1%-3%); (2) significantly greater sedative-like effects of acute ethanol (2.0 or 2.5 g/kg, intraperitoneal [i.p.]) manifested as LORR observed at a lower dose and for longer time, with similar BELs and rates of ethanol clearance; and (3) lower cumulative locomotor activity over 60 minutes in response to an acute ethanol challenge (1.0-2.5 g/kg, i.p.)., Conclusions: The present findings are the first to implicate TAAR1 in the behavioral and reinforcement-related effects of ethanol and raise the question of whether specific drugs that target TAAR1 could potentially reduce alcohol consumption in humans with AUDs.

Human MDMA (R,S-3,4-methylenedioxymethamphetamine) users display selective cognitive deficits after acute MDMA exposure, frequently attributed to serotonin deficits. We postulated that MDMA will compromise executive function in primates and that an inhibitor of the serotonin transporter (SERT) and the norepinephrine transporter (NET) but not the dopamine (DAT) transporter, will prevent impairment. The potencies of DAT/NET, NET and SERT inhibitors to block transport of [(3)H]MDMA and [(3)H]monoamines were compared in vitro. Subsequently, cynomolgus monkeys (Macaca fasicularis) were trained to stable performance in a reversal learning task. Effects of once-weekly oral or i.m. dose of MDMA (1.5 mg/kg, n = 4) on performance were monitored, alone or after pretreatment with inhibitors of the SERT, DAT or NET (prior to i.m. MDMA). 1) Drug potencies for blocking [(3)H]MDMA or [(3)H]monoamine transport were not consistent; 2) Oral MDMA increased error rates in a cognitive task for up to three days following exposure, whereas intramuscular MDMA prevented subjects from performing the cognitive task on the day of administration, but not on subsequent days; 3) The SERT inhibitor citalopram and the NET inhibitor desipramine, but not the DAT/NET inhibitor methylphenidate, reversed the effects of MDMA on task performance and mandibular movements induced by i.m. MDMA and 4) MDMA altered sleep latency. Oral MDMA impairs executive function in monkeys for several days, a finding of potential relevance to MDMA consumption by humans. Reversal of impaired executive function by a NET inhibitor implicates the NET and norepinephrine in MDMA-induced cognitive impairment and may be relevant to therapeutic strategies.

Objective: To determine the Tinetti Gait Assessment's sensitivity for detecting changes in verbally instructed gait in patients with Parkinson's disease., Design: Two-group comparison study with sample of convenience., Setting: Motor Behavior Lab, Department of Physical Therapy, University of Florida., Subjects: Twenty community-dwelling, elderly adults: 10 with moderately disabling Parkinson's disease (PD) recruited from local Parkinson Support Groups and 10 gender- and age-matched adults without PD recruited from the local community., Main Outcome Measures: Tinetti Gait Assessment (TGA) overall scores. All subjects were assessed while walking under five verbally instructed conditions: (1) usual walking, (2) swing arms, (3) take large steps, (4) walk fast, (5) count aloud., Results: A 2 x 5 analysis of variance (group x instructional set) was performed. The PD group scored less than the control group on the TGA regardless of the instructed walking conditions (p < 0.05), however, there was no significant difference in the TGA scores across conditions. The effect size of the instructional set measured by the TGA was greatest for the swing arms condition, though small at 0.25., Conclusion: The TGA is not sensitive for detecting change in the gait impairments observed in moderately disabling PD and, therefore, is not adequate as an assessment to establish short-term goals, guide treatment, or assess the effects of intervention for clients with PD.